Navigation Links
Short stature -a problem

Very short children are more likely to suffer from behavioural problems, a major study has found. Researchers found that treatment with growth hormone not only boosted growth in children, but also improved their conduct and relations with other people. Lead researcher Dr Derick Beens, professor of psychiatry and pediatrics at the University of North Dakota, said: "We believe this work demonstrates that all very short children need to be evaluated thoroughly by psychologists as well as by paediatricians and endocrinologists."//

A sample of 345 short children, aged between five and 16, were tested for intelligence, academic achievement, social skills and behaviour problems before starting growth hormone therapy. They were examined again over a three-year period after starting treatment.

Scientists initially found the children suffered a significant level of emotional and psychological problems including anxiety, depression and attention deficit. Despite achieving lower grades at school, the children had near average IQs, and neither IQ nor achievement test scores changed with treatment.

However, after hormone therapy behaviour problems improved. The children were less anxious, attention improved and they were more open. Dr Beens said: "There are several possible explanations for the improvements.

"One is that growth hormone therapy boosts brain chemicals and neurotransmitters that did not work as well as they would have if hormone secretion had been normal." Behaviour problems in short children improved quickly with six months of hormone replacement therapy, Dr Beens said, but that could not be due to growth alone as height increased slowly.


'"/>




Page: 1

Related medicine news :

1. Bad News for Short People
2. Painkillers Do Not Shorten Dying Patients Lives
3. Shortage of MMR vaccine
4. Short stature -a problem
5. Shorter infants have lower incomes in later life
6. Eye Disorders, A Predictor Of A Shorter Lifespan
7. Shorter Radiation Schedules Found To Be More Effective For Patients With Breast Cancer
8. Short term hormone replacement therapy effective
9. New Eye Surgery Gives Hope To Short-Sighted
10. Short Workouts May Not Prevent Weight Gain And Diseases
11. Short Stature Can Be Treated With A New, Non-Growth Hormone In Future
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/28/2017)... ... 2017 , ... Award-winning medical group Allied Anesthesia today announced ... chair for Orange County health care system CalOptima Friday. CalOptima announced its election ... Mark Refowitz’s term, which runs through June 30 of this year, until another ...
(Date:3/28/2017)... Appleton, WI (PRWEB) , ... March 28, 2017 ... ... how self-funded health plans work, the Self-Funding Success website has recently developed and ... about Self-Funded Health Plans ” was created based on common inquiries the site’s ...
(Date:3/28/2017)... ... March 28, 2017 , ... Prominant bariatric surgeon ... is thrilled to offer the recently FDA-approved Obalon Balloon System to his patients. ... SkyLex Advanced Surgical’s already comprehensive list of weight-loss services. Dr. Liu is ...
(Date:3/28/2017)... ... , ... Oily skin is a common and unwelcomed occurrence in people of all ages, genders ... offer to the discussion of dealing with excess skin oil. “Oily skin is a challenge ... that can help remove the oily shine while keeping the skin fresh and clean,” says ...
(Date:3/27/2017)... , ... March 27, 2017 , ... New patients who ... for leading sleep apnea treatment, with or without a referral. Sleep apnea is often ... can include daytime sleepiness, morning headaches and chronic snoring. , Dr. Braasch seeks ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... Calif. , March 27, 2017  Impax Laboratories, ... has appointed Paul M. Bisaro as Impax,s ... the Company,s Board, effective March 27, 2017. Mr. Bisaro ... served as Interim President and Chief Executive Officer since ... of generic and branded pharmaceutical experience, Mr. Bisaro, 56, ...
(Date:3/27/2017)... Genprex, Inc. , a privately held, clinical-stage biopharmaceutical company developing immunogene ... Chief Operating Officer, is scheduled to present a corporate overview at ... Cancer BioPartnering & Investment Forum: Tuesday, March 28, 2017 at 3:00 ... ... Future Leaders in Biotech Industry – Friday, April 7, 2017 at ...
(Date:3/24/2017)... 2017 Research and Markets has announced ... report to their offering. ... The Cell Therapy Manufacturing Market, 2017-2027 ... of cell therapy manufacturing and focuses both on contract manufacturers ... are anticipated to emerge as viable alternatives to conventional treatment ...
Breaking Medicine Technology: